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Abstract
People with substance use disorders (SUD) have high rates of hospitalization and readmission, 
long lengths of stay, and skyrocketing healthcare costs. Yet, models for improving care are 
extremely limited. We performed a needs assessment and then convened academic and community 
partners, including a hospital, community SUD organizations, and Medicaid accountable care 
organizations, to design a care model for medically complex hospitalized patients with SUD. 
Needs assessment showed that 58% to 67% of participants who reported active substance use said 
they were interested in cutting back or quitting. Many reported interest in medication for addiction 
treatment (MAT). Participants had high rates of costly readmissions and longer than expected 
length of stay. Community stakeholders identified long wait times and lack of resources for 
medically complex patients as key barriers. We developed the Improving Addiction Care Team 
(IMPACT), which includes an inpatient addiction medicine consultation service, rapid-access 
pathways to posthospital SUD treatment, and a medically enhanced residential care model that 
integrates antibiotic infusion and residential addiction care. We developed a business case and 
secured funding from Medicaid and hospital payers. IMPACT provides one pathway for hospitals, 
payers, and communities to collaboratively address the SUD epidemic.
Addiction is a national epidemic that represents both a pressing need and a significant 
burden to the healthcare system.1 Hospitals are increasingly filled with people admitted for 
medical complications of substance use disorders (SUD).2 People with SUD have longer 
lengths of stay (LOS) and high readmission rates.3 Hospitalization often does not address 
the root cause—the SUD. For example, many hospitals replace heart valves and deliver 
prolonged courses of intravenous (IV) antibiotics for endocarditis from injection drug use 
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but do not offer addiction medicine consultation, medication for addiction treatment (MAT), 
or linkage to posthospital SUD treatment.4,5
Hospitalization can provide reachable moments for initiating addiction care.6 Medications 
for opioid7 and alcohol use disorders8 can be started during hospitalization, promoting 
engagement in outpatient SUD care7 and increased uptake of MAT,7–9 and reducing 
readmissions.8,10 Yet, medications for SUD are underprescribed,11,12 and most hospitals 
lack inpatient addiction medicine services and pathways to timely SUD care after discharge. 
Furthermore, traditional SUD treatment programs are often not equipped to manage 
medically complex patients or they have long waitlists.13 Most behavioral-physical health 
integration occurs in ambulatory settings. This fails to engage patients who do not access 
primary care. There is an urgent need for models that can improve care for hospitalized 
patients with SUD.
Here, we describe our experience using patient needs assessment to engage stakeholders and 
drive local systems change. We also describe the resulting care model, the Improving 
Addiction Care Team (IMPACT). Our experience provides a potentially useful example to 
other hospitals and communities seeking to address the national SUD epidemic.
METHODS
Setting
In 2012, Oregon transformed its Medicaid system by establishing 16 regional “coordinated 
care organizations” (CCOs) to improve outcomes and slow healthcare spending.14 In a CCO 
environment, hospitals assume increased financial risk, yet reforms have focused on the 
outpatient setting. Therefore, executive leadership at Oregon Health & Science University 
(OHSU), an urban academic medical center, asked clinician- leaders to design point-of-care 
improvements for Medicaid- funded adults and build on existing models to improve care for 
socioeconomically vulnerable adults.15,16 One priority that emerged was to make 
improvements for hospitalized adults with SUD. Of the adult inpatients at OHSU, 30% have 
Medicaid and 15% have SUD by administrative data alone. Before we started our work, 
OHSU lacked inpatient addiction medicine services.
Local Needs Assessment
To understand local needs and opportunities, we surveyed hospitalized adults with SUD. We 
used the electronic health record to generate a list of inpatients flagged by nurses for risky 
alcohol or drug use. A research assistant screened consecutive adults (≥18 years old) and 
invited those who screened positive for alcohol use (Alcohol Use Disorders Identification 
Test–Consumption [AUDIT-C])17 or drug use (single-item screener)18 to participate. We 
excluded non-English speakers, incarcerated adults, people using only marijuana or tobacco, 
psychiatry inpatients, and people unable to consent. Surveys assessed social and 
demographic factors, healthcare utilization, substance use severity, and treatment experience. 
Participants who reported high-risk illicit drug or alcohol use19 were asked to indicate their 
readiness to change on a 3-point scale developed for this study. Response range included: no 
interest, interest in cutting back, or interest in quitting. A subset of participants completed 













in-depth qualitative interviews exploring patient perceptions of substance use treatment 
needs.20 We obtained hospital administrative data from hospital financial services.
Partner Engagement
We identified community partners with which we had an individual or organizational 
relationship and a common interest and potential for collaboration. All invited partners 
agreed to attend initial meetings. We convened leadership and frontline staff across partners. 
OHSU staff included hospital nursing and social work leaders; infectious disease, 
hospitalist, and addiction physicians; and health services researchers. Community 
organizations included Central City Concern (CCC), a community organization serving 
people facing homelessness and addiction; CODA, Inc., a nonprofit SUD treatment agency; 
and Coram/CVS infusion pharmacy.
Collectively, we reviewed needs assessment findings and examples from the literature7–9 to 
develop strategies to address patient and system needs. We used patient narratives to foster 
alignment and prioritized areas in which integration could improve quality and costs. We 
assumed we would petition OHSU and/or Medicaid CCOs to finance efforts and saved 
potentially challenging budget discussions for later, when partnerships would be more 
developed. Our task force attended more than 3 large-group meetings and numerous small-
group meetings to develop IMPACT.
RESULTS
Needs Assessment
Between September 2014 and April 2015, a research assistant approached 326 patients. Of 
these, 235 (72%) met study inclusion criteria, and 185 (78%) agreed to participate (Table 1). 
Of people who reported any substance use within the preceding 3 months, 58% of alcohol 
users and 67% of drug users said they were interested in cutting back or quitting. Fifty-four 
percent of participants with moderate- to high-risk opioid use and 16% with moderate- to 
high-risk alcohol use reported strong interest in MAT. In qualitative interviews, participants 
described inadequately treated withdrawal, the importance of trust and choice, and long wait 
times as a barriers to entering treatment after hospital discharge.20
Administrative data revealed high rates of hospital readmissions and longer than expected 
LOS (Figure). Mean LOS was 10.26 days—4 days more than medicine patients’. Mean LOS 
was high among participants who required long-term IV antibiotics, particularly those with 
endocarditis or osteomyelitis (21.75 days; range, 1.00–51.00 days). We excluded one outlier 
with a 116-day hospitalization.
Intervention Design
Mapping needs to intervention components—We mapped needs assessment findings 
to 3 main IMPACT components: inpatient addiction medicine consultation service, pathways 
to posthospital SUD treatment, and medically enhanced residential treatment (MERT) (Table 
2).













Inpatient addiction medicine consultation service—We developed this service to 
address patients’ report of high readiness to change and interest in starting MAT in the 
hospital. Community partners highlighted the need for peers to increase engagement and 
trust. Therefore, we included a physician, a social worker, and two peers on our team. The 
inpatient service engages patients, advises on withdrawal and pain, performs SUD 
assessments, initiates MAT, and provides counseling and treatment.
Pathways to posthospital SUD treatment—As pathways from hospital to community 
SUD treatment were lacking, and long administrative wait times limited access to 
community treatment, we employed “in-reach” liaisons—community SUD treatment staff 
who perform in-hospital assessments to triage and coordinate care across systems. Given 
that patients value having treatment choices, we linked pathways to an array of MAT and 
abstinence-based treatments, including office-based, intensive outpatient and residential 
levels of care. For patients who live outside the Portland area, we developed relationships 
with rural stakeholders and engaged the help of the Oregon State Opioid Authority in 
introducing our program to SUD treatment providers around the state.
Medically Enhanced Residential Treatment (MERT)—In many cases where patients 
required prolonged courses of IV antibiotics, hospital stays were longer for two reasons: At-
home central-line self-administration of antibiotics was deemed unsafe, and patients were 
denied admission to a skilled nursing facility due to history of substance use. These long 
LOS create an opportunity to initiate and engage patients in treatment, and to render savings 
by shifting care to a residential addiction treatment setting that can accommodate IV 
antibiotic administration and MAT. We increased residential staffing and collaborated with a 
home infusion pharmacy to administer daily infusions on site.
Funding the Intervention
We used administrative data to estimate potential savings and tailored a business case to 
CCO and hospital payers. The CCO business case centered on hospitalization as an 
opportunity to engage out-of-treatment adults and potentially reduce high-cost readmissions 
by managing physical and behavioral health needs. Working within budgeting time lines, we 
used data from the first 165 participants. These participants had 137 readmissions over a 
mean observation period of 4.5 months. Mean charge per readmission was $31,157 (range, 
$699–$206,596) and was highest for people with endocarditis (mean, $55,493; range, 
$23,204–$145,066) and osteomyelitis (mean, $68,774; range, $29,359–$124,481). We 
estimated that a 10% reduction in 6-month readmissions could avoid $674,863 in charges.
For the hospital, the primary financial incentive was reduced LOS. Given the possibility of 
shortening hospitalization through MERT, we estimated a 20% mean LOS reduction; for 
budgeting, we estimated a conservative 10% reduction. A 10% mean LOS reduction would 
free 205 bed-days (10% × 10.26 days mean LOS × 200 patients) and create space for 
another 32 inpatient admissions in year 1, assuming no change from medical patients’ 6.26 
days mean LOS. The future of bundled payments further bolstered our business case, as did 
the potential to improve care quality, reduce nonproductive staff time, and increase 
institutional learning about SUD. Overall program costs approximated projected savings, 













and the hospital and a local CCO agreed to equally share the costs of the intervention (Table 
2).
DISCUSSION
We have described an innovative approach to developing an SUD intervention for 
hospitalized adults. Using a process of broad stakeholder engagement, data-driven 
understanding of population needs, and analysis of financial incentives, we built consensus 
and secured funding for a multicomponent intervention across hospital and post–acute care 
settings. Other studies have demonstrated the feasibility and efficacy of starting a single 
medication for a specific indication7–9 (eg, methadone for opioid use disorder), yet strategies 
for expanding SUD services in hospitals and facilitating posthospital treatment linkages 
remain scarce.21 Our model addresses a widespread need and could be adapted to other 
hospitals, SUD treatment organizations, and Medicaid payers.
Our experience has several limitations. First, it took place at a single academic medical 
center in Oregon, a Medicaid expansion state. Second, our needs assessment involved a 
convenience sample of limited racial/ethnic diversity. Third, almost all patients had 
insurance, which could limit generalizability. Fourth, to secure funding, it was essential we 
had a clinical champion who was persuasive with hospital and CCO leadership; though 
increasing disease burden and skyrocketing costs2 may drive administrators’ increased 
demand for ways to address SUD in hospitalized adults.
Our experience has several key implications. First, diverse partners were vital at all stages of 
program design, suggesting hospitals should look beyond traditional healthcare partners to 
address the SUD epidemic. Second, an interprofessional team that includes physicians, 
social workers, and peers may better engage patients and address complex system needs. 
Finally, a planned IMPACT evaluation will assess effects on substance use, healthcare use, 
and costs.
The United States faces a burgeoning SUD epidemic. Our experience describes an 
innovative care model and supports the idea that hospitals may play a leading role in 
convening partners, providing treatment, and driving population health improvements for 
adults with SUD.
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Hospital LOS among needs assessment patients.
NOTE: Abbreviations: GMLOS, geometric length of stay; LOS, length of stay.





























Substance Use n (%)
Total participants 185
Any alcohol use in the past 3 months 109/185 (59)
Any opioid use in the past 3 months 68/185 (37)
Any druga use in the past 3 months 137/185 (74)
Interest in cutting back or quitting
  Alcohol 63/109 (58)
  Drugs 92/137 (67)
Moderate – high risk substance use
  Alcohol 82/185 (44)
  Amphetamines 74/185 (40)
  Opioids 72/185 (39)
  Cocaine 23/185 (12)
Past 3 month polysubstance use 113/185 (61)
Interest in MAT for alcohol use disorder among moderate-high risk users 13/82 (16)
Interest in MAT for opioid use disorder among moderate-high risk users
  Any MAT 39/72 (54)
  Methadone 26/72 (36)
  Buprenorphine 23/72 (32)
a
Cocaine, amphetamines, inhalants, sedatives, hallucinogens, opioids.
NOTE:
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Year 1 Enrollment 








Social worker performs ASAM assessment, 
uses motivational interviewing to engage 
patients, initiates evidence-based SUD 
treatment, and coordinates posthospital 
addiction care
0.5 FTE physician—half-day 
weekday coverage based on 
projection that half the patients 
would need physician consultation 
and MAT
OHSU lacked expertise to 
assess, engage, and initiate 
SUD treatment
200 patients Physician advises on withdrawal and pain 
management and initiates MAT
1.0 FTE social worker—expected 
case load of about 6–8 patients/day
Engagement and trust are 
key
Peers support patient engagement in hospital 
and across transition to community SUD care
1.4 FTE peer mentors—peers 
would be present 7 days/week, 
including some evening hours
No pathways from hospital 





community SUD care 
after hospital 
discharge
CADCs from partner organizations “reach in” 
to hospital, describe community treatment 
options, support triage and linkage, and serve 
as points of contact as patients transition 
across hospital, jail, skilled nursing facility, 
and community SUD treatment
0.5 FTE CADC—at each partner 
site
Long community wait times 100 patients
Patients who require long 
courses of IV antibiotics 




Treatment brings IV 
antibiotics and nursing 
care into residential 
addiction setting
Home infusion pharmacy administers daily IV 
antibiotics and performs weekly central 
catheter dressing changes
Payment for 6 days/week home 
infusion pharmacy costs (insurance 
plans cover once-weekly home 
infusion)
Residential SUD treatment 
programs not equipped for 
medically complex patients
30 patients Registered nurse supports care coordination 
and on-site infusion, basic wound care, and 
other nursing needs
0.7 FTE registered nurse
Physician prescribes MAT in residential 
program and provides oversight for medically 
complex patients
0.1 FTE community addiction 
physician
Residential program coordinator manages bed 
flow to support timely access to residential 
beds
0.2 FTE residential program 
coordinator
Infectious disease team uses video technology 
to conduct weekly virtual bedside rounds
Hospital infectious disease team 
supports 30 minutes/week 
telehealth rounds
NOTE:
Abbreviations: ASAM, American Society of Addiction Medicine; CADC, certified alcohol and drug counselor; FTE, full-time equivalent; 
IMPACT, Improving Addiction Care Team; IV, intravenous; MAT, medication for addiction treatment; OHSU, Oregon Health & Science 
University; SUD, substance use disorder.
